there was no immediate plan to increase production to its new capacity.
"The current rare earths market remains subdued," Lynas said yesterday. "In response to this macro environment, Lynas is optimising production at the phase one capacity level”?
Sydney-based Lynas said it planned to continue processing about 11,000 tonnes a year instead of boosting volume to the new capacity of 22,000 tonnes.
----------
No longer to question, before in a future announce that Lynas will "plan to increase production to its new capacity", All of calculations about CoP, profit, PE...
should be better to based on the phase one capacity (11000T), otherwise, that would be as the blind optimism with no factual basis.
"optimising production" will certainly reduce costs, improve value-added to products;
But the total of capacity will reduce by 50%, means the profits will slash by half.
Key questions:
how much margin the phase one capacity's profits will bring eventually?
If the meager margin?
If only the financial balance?
If the loss?
how about the impact of each case to the shareprice?
worthy to discussion.
Of course, I hope to see a huge profits. But may do?
- Forums
- ASX - By Stock
- LYC
- News: Lynas to cut costs
News: Lynas to cut costs , page-30
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.36 |
Change
-0.045(0.70%) |
Mkt cap ! $5.954B |
Open | High | Low | Value | Volume |
$6.46 | $6.47 | $6.35 | $14.89M | 2.330M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
34 | 20967 | $6.35 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.36 | 17226 | 36 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 5787 | 6.360 |
25 | 21076 | 6.350 |
12 | 24938 | 6.340 |
10 | 32856 | 6.330 |
9 | 88539 | 6.320 |
Price($) | Vol. | No. |
---|---|---|
6.370 | 50366 | 37 |
6.380 | 47049 | 27 |
6.390 | 40135 | 13 |
6.400 | 22762 | 12 |
6.410 | 13537 | 8 |
Last trade - 15.31pm 15/07/2024 (20 minute delay) ? |
Featured News
LYC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online